Comparison of Two Argentine Registries on Myocardial Infarction: the 2011 SCAR Registry and the 2015 AR GEN -IA M-ST Registry

Claudio Higa, Heraldo D´Imperio, Patricia Blanco, Adrián Charask, Hernán Cohen Arazi, Fedor Novo, Eduardo Perna, Juan Gagliardi

Abstract


Background: The aim of this study was to compare patients with ST-segment elevation myocardial infarction (STEMI) included incenters participating of two registries in Argentina.Methods: STEMI patients included in the 54 centers participating in the SCAR (2011) registry and in the ARGEN-IAM-ST (2015)registry were compared.Results: A total of 676 STEMI patients were analyzed: 222 in the SCAR registry and 454 in the ARGEN-IAM-ST registry. There wereno significant differences in age and sex. The use of fibrinolytic agents was significantly lower and the use of primary percutaneouscoronary intervention was significantly increased. The incidence of cardiogenic shock was 50% lower. There were no differences inmortality and reinfarction during hospitalization.Conclusions: The indication of primary percutaneous coronary intervention increased and the use of fibrinolytic agents decreased.Cardiogenic shock decreased significantly in the last 5 years without significant changes in in-hospital mortality.

References


WHO. World Health Organization - NCD Country Profiles. (OMS) 2014. http://www.who.int/countries/arg/en/. 04-08-2016 3

Ministerio de Salud de la Nación. Reporte de Establecimientos. Eventos enfermedades y mortalidad. www.deis.msal.gov.ar. 2016

Roe MT, Messenger JC, Weintraub WS, Cannon CP, Fonarow GC, Dai D, et al. Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol 2010;56:254-63. http://doi.org/bxfh9d

Andersen HR, Nielsen TT, Vesterlund T, Grande P, Abildgaard U, Thayssen P, et al. Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarc¬tion: rationale and design of the DANish trial in Acute Myocardial Infarction-2 (DANAMI-2). Am Heart J 2003;146:234-41. http://doi. org/cg645d

Widimsky P, Budesinsky T, Vorac D, Groch L, Zelizko M, Ascher¬mann M, et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial- PRAGUE-2. Eur Heart J 2003;24:94-104. http://doi.org/b7xthv

Steg PG, Bonnefoy E, Chabaud S, Lapostolle F, Dubien PY, Cristo¬fini P, et al. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM random¬ized clinical trial. Circulation 2003;108:2851-6. http://doi.org/fpjchx

López AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747-57. http://doi.org/chhv5q

García Aurelio MJ, Cohen Arazi H, Higa C, Gómez HR, Mauro V, Fernández H, y cols. Infarto agudo de miocardio con supradesnivel persistente del segmento ST. Registro multicéntrico SCAR (Sín¬dromes Coronarios Agudos en Argentina) de la Sociedad Argentina de Cardiología. Rev Argent Cardiol 2014;82:275-84. http://doi.org/4wz

Gagliardi JA, Charask A, Perna E, D´Imperio H, Bono H, Castillo Y, y cols. Encuesta nacional de infarto agudo de miocardio con elevación del ST en la República Argentina (ARGEN-IAM-ST) Rev Argent Cardiol. 2016;84:548-57. http://doi.org/b63n

Programa de Indicadores de Calidad en la Atención Médica de SACAS (Sociedad Argentina de Calidad en Atención de la Salud) / ITAES (Instituto Técnico para la Acreditación de Establecimientos de Salud). http://www.calidadensalud.org.ar

Piombo A, Rolandi M, Fitz Maurice M, Salzberg S, Zylberstein H, Rubio E y cols. Registro de calidad de atención del infarto agudo de miocardio en los hospitales públicos de la Ciudad de Buenos Aires. Rev Argent Cardiol 2011;79:132-8.

Mariani J, De Abreu M, Tajer C, en representación de los investiga¬dores de la Red para la Atención de los Síndromes Coronarios Agudos. Tiempos y utilización de terapia de reperfusión en un sistema de atención en red. Rev Argent Cardiol 2013;81:233-9. http://doi.org/s2r

Kim JH, Chae SC, Oh DJ, Kim HS, Kim YJ, Ahn Y, et al; Korea Acute Myocardial Infarction-National Institutes of Health Registry Investigators. Multicenter Cohort Study of Acute Myocardial In¬farction in Korea- Interim Analysis of the Korea Acute Myocardial Infarction Registry-National Institutes of Health Registry. Circ J. 2016;80:1427-36. http://doi.org/cwq5

Lee JM, Rhee TM, Hahn JY, Kim HK, Park J, Hwang D, et al; KAMIR Investigators. Multivessel Percutaneous Coronary Interven¬tion in Patients with ST-Segment Elevation Myocardial Infarction with Cardiogenic Shock. J Am Coll Cardiol. 2018;71:844-56. http:// doi.org/gc3wq3

Saar A, Marandi T, Ainla T, Fischer K, Blöndal M, Eha J. The risk-treatment paradox in non-ST-elevation myocardial infarction patients according to their estimated GRACE risk. Int J Cardiol. 2018;272:26-32. http://doi.org/cwq6


Full Text

Refbacks

  • There are currently no refbacks.


Licencia Creative Commons
The documents published in this journal are under the licencia Creative Commons Atribución-NoComercial-Compartir-Igual 2.5 Argentina.

Revista argentina de cardiología. ISSN en línea 1850-3748. Argentine journal of cardiology (English ed. Online ISSN 2314-2286) Sociedad Argentina de Cardiología. Azcuénaga 980 (C1115AAD),Ciudad Autónoma de Buenos Aires, República Argentina. Tel. (54 11) 4961-6027/8/9 Fax: 4961-6020 www.sac.org.ar revista@sac.org.ar